Scientific Advisory Board
Dr Tim Corn
Dr Tim Corn is Chief Medical Officer at EUSA Pharma International, a division of Jazz Pharmaceuticals and also serves as Non-executive Director on the Boards of Circassia Limited and Reneuron plc.
Dr. Corn qualified in medicine at King's College Hospital, London after gaining a Master's degree in biochemistry from Imperial College. He became consultant and senior lecturer in neuropsychiatry at the Institute of Psychiatry, London, and is the author of more than forty scientific publications. Dr Corn has held senior positions at GlaxoWellcome, MSDRL, Athena Neuroscience, Elan and Zeneus as well as in the UK regulatory agency, and has played a key role in twenty regulatory approvals for products in the fields of neurology and oncology. He was elected Fellow of the Faculty of Pharmaceutical Medicine in 1996 and of the Royal College of Psychiatrists in 1998.
Prof. Frank Lin
(Johns Hopkins University, Baltimore )
Frank R. Lin, M.D. Ph.D. is an Assistant Professor of Otolaryngology, Geriatric Medicine, Mental Health, and Epidemiology at Johns Hopkins University. Dr. Lin completed his medical education and residency in Otolaryngology-Head & Neck Surgery at the Johns Hopkins School of Medicine and his Ph.D. at the Johns Hopkins Bloomberg School of Public Health. He completed further otologic fellowship training in Lucerne, Switzerland with Professors Thomas Linder and Ugo Fisch. Dr. Lin's clinical practice is dedicated to the medical and surgical management of otologic conditions, and his research is focused on studying questions at the interface of hearing loss, gerontology, and public health.
Prof. Bill Deakin
(University of Manchester)
Professor Bill Deakin graduated in Medicine at Leeds University having obtained with a 1st in Physiology on the way. He specialised in Psychiatry and joined the Clinical Research Centre at Northwick Park, London, a MRC schizophrenia research unit. He was a MRC Training Fellow for 5 years and he obtained his PhD on the role of 5HT (serotonin) neurone pathways in rat behaviour.
Bill is Professor of Psychiatry at the University of Manchester. His group have produced novel insights into molecular, neurotransmitter and cognitive mechanisms of psychosis, mood disorders and addictions. This has led to new treatment approaches in schizophrenia through research council and industry funding.
Bill is the experimental medicine lead of the UK Mental Health Research Network, a National Institute for Health Research Senior Investigator and a Fellow of the Academy of Medical Sciences.
Prof. David McAlpine
(UCL Ear Institute)
David McAlpine is Professor of Auditory Neuroscience at University College London, and Director of the UCL Ear Institute. Following undergraduate studies at the University of Western Australia, he read for his doctorate at Oxford University beforing moving to the MRC Institute of Hearing Research, Nottingham as an MRC Training Fellow. Following a short period as a lecturer at Sheffield University, he moved in to UCL in 1999, and has held the Directorship of the Ear Institute since 2006. In collaboration with the Royal National Throat Nose and Ear Hospital he have overseen the development of a translational research programme designed to ensure that basic scientific findings find their way to the clinic. His own research interests include investigations into brain mechanisms underlying spatial hearing, cochlear implantation and biological advances in hearing therapies including tinnitus.